LPL and liver cancer: Taken together, depending on the relative contribution of LIPA and the other nine genes’ expression levels, the fate of the disease will be inflammatory response associated to CD36, LPL, and SCD leading to NASH progression into liver cancer or cirrhosis and HCC as shown in Figure 5B.